Headlines
Europe should diversify drug supplies to face health crises, ministers say
Published by Global Banking and Finance Review
Posted on March 9, 2025
2 min readLast updated: January 25, 2026
Global Banking and Finance Review
Company
Published by Global Banking and Finance Review
Posted on March 9, 2025
2 min readLast updated: January 25, 2026
Europe plans to diversify drug supplies to reduce dependency on Asia, enhancing preparedness for health crises. Ministers urge EU action.
FRANKFURT (Reuters) -Europe should reduce its dependence on a small number of countries for vital drug supplies such as antibiotics and anaesthetics to boost the bloc's preparedness for future health crises, a group of ministers has recommended.
The health ministers of 11 European Union countries made the recommendation ahead of EU Commission proposals for a draft Critical Medicine Act (CMA) due on Tuesday.
"(Between) 80% and 90% of antibiotics are made in Asia, mostly China," they said in a letter dated March 8, which was seen by Reuters after being published by Euronews.
"It is easy for foreign actors to turn this dependency into a critical vulnerability, one that could severely undermine Europe's security and defence capabilities," said the letter, whose signatories included German Health Minister Karl Lauterbach.
Price pressure on cheap generics along with higher labour and environmental costs, has driven medicine production away from Europe, leaving it exposed, it said, urging the EU Commission to include the CMA in a broader security framework.
The ministers said that could be done along the lines of the U.S., where pharmaceuticals are considered part of defence goods supply chains, and proposed ramping up domestic production and centralised stockpiling, when possible.
"Several medicines, including antibiotics, anaesthetics, and thrombolytics, are not only vital for civilian healthcare but also for military and emergency scenarios," they said.
(Reporting by Andreas Rinke;Writing by Vera Eckert;Editing by Helen Popper)
European health ministers recommend reducing dependence on a few countries for vital drug supplies to enhance preparedness for health crises.
Europe's vulnerability stems from the fact that 80% to 90% of antibiotics are produced in Asia, primarily China, making the region reliant on foreign production.
The ministers propose ramping up domestic production of pharmaceuticals and considering them part of defense goods supply chains, similar to the U.S. approach.
Medicines such as antibiotics, anaesthetics, and thrombolytics are emphasized as essential for both civilian healthcare and military emergency scenarios.
Price pressure on cheap generics, along with higher labor and environmental costs, has led to a decline in medicine production within Europe.
Explore more articles in the Headlines category
